RESECTED PANCREATIC ADENOCARCINOMA
Clinical trials for RESECTED PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTED PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RESECTED PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to keep pancreatic cancer at bay after surgery
Disease control Recruiting nowThis study tests a new drug called daraxonrasib to see if it can delay or prevent pancreatic cancer from returning after surgery and chemotherapy. About 500 adults who have had their pancreatic cancer removed will be randomly assigned to receive the drug or just be watched. The g…
Matched conditions: RESECTED PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
Smart chemo strategy aims to outsmart pancreatic cancer recurrence
Disease control Recruiting nowThis study tests whether giving different types of chemotherapy after surgery, based on how much the tumor shrank with initial chemo, can help prevent pancreatic cancer from coming back. About 390 adults who had surgery after 3 months of a specific chemo (mFOLFIRINOX) will be ass…
Matched conditions: RESECTED PANCREATIC ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 14, 2026 12:06 UTC